NO883200L - Farmasoeytisk preparat for intranasal administrering omfattende gh-frigivende hormon, en cholinergagonist og eventuelt et galle-salt. - Google Patents

Farmasoeytisk preparat for intranasal administrering omfattende gh-frigivende hormon, en cholinergagonist og eventuelt et galle-salt.

Info

Publication number
NO883200L
NO883200L NO88883200A NO883200A NO883200L NO 883200 L NO883200 L NO 883200L NO 88883200 A NO88883200 A NO 88883200A NO 883200 A NO883200 A NO 883200A NO 883200 L NO883200 L NO 883200L
Authority
NO
Norway
Prior art keywords
intranasal administration
salt
cholinergagonist
galle
pharmaceutical preparation
Prior art date
Application number
NO88883200A
Other languages
English (en)
Norwegian (no)
Other versions
NO883200D0 (no
Inventor
Franklin M Boghen
Franco Camanni
Piero Del Soldato
Ezio Ghigo
Eugenio E Muller
Original Assignee
Pierrel Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierrel Spa filed Critical Pierrel Spa
Publication of NO883200D0 publication Critical patent/NO883200D0/no
Publication of NO883200L publication Critical patent/NO883200L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO88883200A 1987-07-30 1988-07-19 Farmasoeytisk preparat for intranasal administrering omfattende gh-frigivende hormon, en cholinergagonist og eventuelt et galle-salt. NO883200L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21513/87A IT1222395B (it) 1987-07-30 1987-07-30 Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare

Publications (2)

Publication Number Publication Date
NO883200D0 NO883200D0 (no) 1988-07-19
NO883200L true NO883200L (no) 1989-01-31

Family

ID=11182925

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88883200A NO883200L (no) 1987-07-30 1988-07-19 Farmasoeytisk preparat for intranasal administrering omfattende gh-frigivende hormon, en cholinergagonist og eventuelt et galle-salt.

Country Status (12)

Country Link
US (1) US5010056A (de)
EP (1) EP0301392B1 (de)
JP (1) JPS6450823A (de)
KR (1) KR890001584A (de)
AT (1) ATE76753T1 (de)
AU (1) AU618547B2 (de)
DK (1) DK393188A (de)
IT (1) IT1222395B (de)
NO (1) NO883200L (de)
NZ (1) NZ225546A (de)
PH (1) PH26712A (de)
ZA (1) ZA885417B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0383931A (ja) * 1989-08-29 1991-04-09 Sumitomo Pharmaceut Co Ltd 低刺激性ｇｒｆ経鼻投与製剤
DE69001991T2 (de) * 1989-11-16 1993-09-23 Phidea Spa Fluessige arzneimittel zur nasalen anwendung, die ein polypeptid als wirksubstanz enthalten.
US5502067A (en) * 1994-02-04 1996-03-26 Morgan; Julia A. Treating apneahypopnea/snoring in humans
US5500205A (en) * 1994-02-23 1996-03-19 Enviro Pac International, L.I.C. Lachrymator aerosol formulations
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
AUPN801296A0 (en) * 1996-02-12 1996-03-07 Csl Limited Stabilised growth hormone formulation and method of preparation thereof
ATE277596T1 (de) * 1997-02-24 2004-10-15 Sla Pharma Ag Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
US8048875B1 (en) 1997-02-24 2011-11-01 S.L.A. Pharma Ag Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
AU772798B2 (en) * 1999-04-21 2004-05-06 1355540 Ontario Inc. Formulations for detecting asthma
EP1189596A1 (de) * 1999-06-02 2002-03-27 Norbert Dr.med. Klöcker Pharmazeutische zusammensetzung zur nasalen anwendung von wasserlöslichen wirkstoffen
CA2325106A1 (en) * 1999-12-06 2001-06-06 Stanley L. Gore Compositions and methods for intranasal delivery of active agents to the brain
JP3498041B2 (ja) 2000-05-29 2004-02-16 科研製薬株式会社 プラルモレリン含有点鼻用製剤
WO2010135731A1 (en) * 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
JP6556129B2 (ja) * 2013-08-01 2019-08-07 アメリカ合衆国 ファルネソイドｘ受容体の阻害剤及び医薬としての使用
KR20230058444A (ko) * 2020-08-26 2023-05-03 오티카라 인코포레이티드 코, 귀 및 다른 조직 감염 및/또는 염증을 치료하기 위한 조성물, 디바이스 및 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0625068B2 (ja) * 1982-12-10 1994-04-06 シンテツクス（ユ−・エス・エ−・）インコ−ポレイテイド 鼻腔内投与用組成物及びその製造方法
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
IT1169873B (it) * 1983-10-21 1987-06-03 Prodotti Formenti Srl Composizione farmaceutica ad attivita' sistemica anticolinesterasica, agonista-colinergica ed antimuscarinica
US4818531A (en) * 1985-02-06 1989-04-04 Eli Lilly And Company Growth hormone and thyroid hormone
JPS62126135A (ja) * 1985-11-25 1987-06-08 Sumitomo Pharmaceut Co Ltd 経鼻投与用ｇｒｆ製剤
US4663318A (en) * 1986-01-15 1987-05-05 Bonnie Davis Method of treating Alzheimer's disease
US4880778A (en) * 1986-05-12 1989-11-14 Eastman Kodak Company Combinations having synergistic growth hormone releasing activity and methods for use thereof

Also Published As

Publication number Publication date
PH26712A (en) 1992-09-15
KR890001584A (ko) 1989-03-27
ATE76753T1 (de) 1992-06-15
NO883200D0 (no) 1988-07-19
US5010056A (en) 1991-04-23
IT1222395B (it) 1990-09-05
EP0301392B1 (en) 1992-06-03
AU618547B2 (en) 1992-01-02
JPS6450823A (en) 1989-02-27
NZ225546A (en) 1990-12-21
ZA885417B (en) 1989-06-28
EP0301392A1 (de) 1989-02-01
DK393188D0 (da) 1988-07-14
DK393188A (da) 1989-01-31
AU2005188A (en) 1989-02-02
IT8721513A0 (it) 1987-07-30

Similar Documents

Publication Publication Date Title
NO883200D0 (no) Farmasoeytisk preparat for intranasal administrering omfattende gh-frigivende hormon, en cholinergagonist og eventuelt et galle-salt.
FI875645A0 (fi) Menetelmä nestemäisen annostelumuodon valmistamiseksi farmaseuttisesti aktiivisen aineen oraalista antoa varten
IT1218548B (it) Perno autofilettante per l'impianto di protesi dentali
ATE110565T1 (de) Verfahren und zubereitungen zur hemmung von mit oxidativer schädigung assoziierten krankheiten.
NO884625D0 (no) N-substituerte derivater av 1-desoksynojirimycin og 1-desoksymannojirimycin, fremgangsmaate for deres fremstilling og deres anvendelse i legemiddel.
NO880193L (no) Vevveksthjelpemiddel og fremstilling derav.
OA08214A (en) Apparatus and methodology for pulsed administration of growth promoting agents.
EP0242643A3 (en) Nasal administration of drugs
NO885797D0 (no) Karboksylsyrederivater med terapeutisk virkning og fremgangsmaate til deres fremstilling.
DK128688D0 (da) Thiazolderivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne
ITMI911791A1 (it) Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari.
NO880434D0 (no) Anestetisk preparat og fremgangsmaate for bruk derav.
DK122391D0 (da) Terapeutisk aktiv, substitueret benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
NO167734C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
MY103210A (en) Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
DK567188D0 (da) 2,2-dimethylchromenderivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne
DK598288A (da) Vaeskeformig farmaceutisk sammensaetning til behandling af hoste og oemhed i halsen
NO167664C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive castanosperminestere og glycosider.
DK134990D0 (da) Praeparat til tandbehandling samt fremgangsmaade til fremstilling deraf
DK325289A (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
EP0355612A3 (en) New furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
NO870834D0 (no) Glysero-3(2)-fosfo-l-serinderivater og salter derav, fremgangsmaater for fremstilling derav og farmasoeytiske preparater inneholdende derivatene.
NO881554L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-((1,1-difenyl)-1-alkenyl)piperazin-derivater og farmasoeytisk aksepterbare salter av disse derivater.
NO920524D0 (no) Kynurensyrederivater, deres fremstilling og farmasoeytiskeblandinger inneholdende disse